Shift in pre-existing antibiotic heteroresistance explains change in antimicrobial susceptibility status from susceptible to resistant during patient treatment.
Ben Kittleson, Carter N Abbott, Keith S Kaye, David S Weiss
{"title":"Shift in pre-existing antibiotic heteroresistance explains change in antimicrobial susceptibility status from susceptible to resistant during patient treatment.","authors":"Ben Kittleson, Carter N Abbott, Keith S Kaye, David S Weiss","doi":"10.1016/j.lanmic.2026.101420","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101420"},"PeriodicalIF":20.4000,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Microbe","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.lanmic.2026.101420","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
期刊介绍:
The Lancet Microbe is a gold open access journal committed to publishing content relevant to clinical microbiologists worldwide, with a focus on studies that advance clinical understanding, challenge the status quo, and advocate change in health policy.